ARCHIVES

Dose Dense Chemotherapy Regimen Improves Survival In Breast Cancer

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

FDA Committee Agenda Includes M-AMSA, THC, Estramustine, Platinum

May 22, 1981

In Brief: Kennedy, Waxman May Agree On Simple Extension Of Biomedical Research Authority, Including NCI

November 21, 1980

ASSIST Smoking Intervention gets Under Way In 1991

December 1, 1989

NIH Balks At Forming New Review Groups For NCI’s Program Grants; Guidelines Draft Ready For NCAB

August 2, 1974

ACS To Accept Database On Method Of Unconventional Rx

November 26, 1993

Politics May Play Role In FDA’s Avastin Decision

May 27, 2011